[ESPR] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
28-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -20.29%
YoY- -58.45%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 15,401 9,638 982 184,474 0 0 0 -
PBT -65,119 -104,476 -61,946 -60,039 -37,891 -28,956 -13,122 30.57%
Tax 13,430 8,795 5,165 -74 807 423 287 89.71%
NP -65,119 -104,476 -61,946 -60,039 -37,891 -28,956 -13,122 30.57%
Tax Rate - - - - - - - -
Total Cost 80,520 114,114 62,928 244,513 37,891 28,956 13,122 35.26%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -422.82 -1,084.00 -6,308.15 -32.55 0.00 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -1.77 -3.89 -2.26 -2.24 -1.44 -1.28 -0.58 20.41%
EPS Diluted -1.77 -3.89 -2.26 -2.24 -1.44 -1.28 -0.58 20.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.